I
Ignacio Monedero
Researcher at International Union Against Tuberculosis and Lung Disease
Publications - 16
Citations - 982
Ignacio Monedero is an academic researcher from International Union Against Tuberculosis and Lung Disease. The author has contributed to research in topics: Tuberculosis & Extensively drug-resistant tuberculosis. The author has an hindex of 8, co-authored 16 publications receiving 799 citations.
Papers
More filters
Journal ArticleDOI
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad,Shama D. Ahuja,Onno W. Akkerman,Jan-Willem C. Alffenaar,Laura F Anderson,Parvaneh Baghaei,Didi Bang,Pennan M. Barry,Mayara Lisboa Bastos,Digamber Behera,Andrea Benedetti,Gregory P. Bisson,Martin J. Boeree,Maryline Bonnet,Sarah K. Brode,James C.M. Brust,Ying Cai,Eric Caumes,J. Peter Cegielski,Rosella Centis,Pei-Chun Chan,Edward D. Chan,Kwok-Chiu Chang,Macarthur Charles,Andra Cirule,Margareth Pretti Dalcolmo,Lia D'Ambrosio,Gerard de Vries,Keertan Dheda,Aliasgar Esmail,Jennifer Flood,Gregory J. Fox,Mathilde Fréchet-Jachym,Geisa Fregona,Regina Gayoso,Medea Gegia,Maria Tarcela Gler,Sue Gu,Lorenzo Guglielmetti,Timothy H. Holtz,Jennifer Hughes,Petros Isaakidis,Leah G. Jarlsberg,Russell R. Kempker,Salmaan Keshavjee,Faiz Ahmad Khan,Maia Kipiani,Serena P. Koenig,Won-Jung Koh,Afranio Lineu Kritski,Liga Kuksa,Charlotte Kvasnovsky,Nakwon Kwak,Zhiyi Lan,Christoph Lange,Rafael Laniado-Laborín,Myungsun Lee,Vaira Leimane,Chi-Chiu Leung,Eric Chung Ching Leung,Pei Zhi Li,Phil Lowenthal,Ethel Leonor Noia Maciel,Suzanne M. Marks,Sundari Mase,Lawrence Mbuagbaw,Giovanni Battista Migliori,Vladimir Milanov,Ann C. Miller,Carole D. Mitnick,Chawangwa Modongo,Erika Mohr,Ignacio Monedero,Payam Nahid,Norbert Ndjeka,Max R. O'Donnell,Nesri Padayatchi,Domingo Palmero,Jean W. Pape,Laura Jean Podewils,Ian R Reynolds,Vija Riekstina,Jérôme Robert,Maria I. Rodriguez,Barbara Seaworth,Kwonjune J. Seung,Kathryn Schnippel,Tae Sun Shim,Rupak Singla,Sarah Smith,Giovanni Sotgiu,Ganzaya Sukhbaatar,Payam Tabarsi,Simon Tiberi,Anete Trajman,Lisa Trieu,Zarir F Udwadia,Tjip S. van der Werf,Nicolas Veziris,Piret Viiklepp,Stalz Charles Vilbrun,Kathleen F. Walsh,Janice Westenhouse,Wing Wai Yew,Jae-Joon Yim,Nicola M. Zetola,Matteo Zignol,Dick Menzies +107 more
TL;DR: Treatment outcomes were significantly better with use of linezolid, later generation fluoroquinolones, bedaquiline, clofazimine, and carbapenems for treatment of multidrug-resistant tuberculosis, and the need for trials to ascertain the optimal combination and duration of these drugs is emphasised.
Journal ArticleDOI
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
Christoph Lange,Ibrahim Abubakar,Jan-Willem C. Alffenaar,Graham H. Bothamley,Jose A. Caminero,Anna Cristina Calçada Carvalho,Kwok Chiu Chang,Luigi Codecasa,Ana Maria Correia,Valeriu Crudu,Peter Davies,Martin Dedicoat,Francis Drobniewski,Raquel Duarte,Cordula Ehlers,Connie Erkens,Delia Goletti,Gunar Günther,Elmira Ibraim,Beate Kampmann,Liga Kuksa,Wiel C M de Lange,Frank van Leth,Jan Van Lunzen,Alberto Matteelli,Dick Menzies,Ignacio Monedero,Elvira Richter,Sabine Rüsch-Gerdes,Andreas Sandgren,Anna Scardigli,Alena Skrahina,Enrico Tortoli,Grigory V. Volchenkov,Dirk Wagner,Marieke J. van der Werf,Bhanu Williams,Wing Wai Yew,Jean-Pierre Zellweger,Daniela Maria Cirillo +39 more
TL;DR: This document summarises the current knowledge on the prevention, diagnosis and treatment of adults and children with MDR/XDR-TB and their contacts, and provides expert consensus recommendations on questions where scientific evidence is still lacking.
Journal ArticleDOI
Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?
Arnaud Trébucq,Donald A. Enarson,C. Y. Chiang,A. Van Deun,Anthony D. Harries,F. Boillot,Anne Detjen,P. I. Fujiwara,Stephen M. Graham,Ignacio Monedero,I. D. Rusen,Hans L. Rieder +11 more
TL;DR: The positive predictive value by Xpert MTB/RIF is high, and identification of RMP resistance is an excellent proxy for multidrug-resistant TB (MDR-TB), and the assay should be widely used for this purpose if, and only if, excellent MDR- TB management is available.
Journal ArticleDOI
Management of multidrug-resistant tuberculosis: an update.
TL;DR: This paper is a critical review of current best practice regarding the diagnosis and treatment of MDR-TB.
Management of Tuberculosis
Nadia Aït-Khaled,Edith Alarcon,Raimond Armengol,Karen Bissell,François Boillot,Jose A. Caminero,Chiang Chen-Yuan,Philippe Clevenbergh,Riitta A Dlodlo,Donald A. Enarson.,P M Enarson,Paula I Fujiwara,Anthony D. Harries,Einar Heldal,Sven Gudmund Hinderaker,Ignacio Monedero,Hans L. Rieder,I. D. Rusen,Arnaud Trébucq,Armand Van Deun,Nevin Wilson +20 more